Published in Nature on September 23, 2009
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol (2010) 24.08
IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol (2010) 8.97
The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol (2010) 7.47
STING is a direct innate immune sensor of cyclic di-GMP. Nature (2011) 6.44
The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat Immunol (2011) 5.34
The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat Immunol (2010) 4.58
Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis. Proc Natl Acad Sci U S A (2010) 4.57
Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response. Proc Natl Acad Sci U S A (2009) 4.48
TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria. Cell (2012) 4.44
Autophagy in infection, inflammation and immunity. Nat Rev Immunol (2013) 4.16
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells. J Exp Med (2011) 4.02
The N-ethyl-N-nitrosourea-induced Goldenticket mouse mutant reveals an essential function of Sting in the in vivo interferon response to Listeria monocytogenes and cyclic dinucleotides. Infect Immun (2010) 3.89
Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome. Immunity (2011) 3.74
Immunomodulatory functions of type I interferons. Nat Rev Immunol (2012) 3.73
Intracellular DNA recognition. Nat Rev Immunol (2010) 3.70
cGAS produces a 2'-5'-linked cyclic dinucleotide second messenger that activates STING. Nature (2013) 3.60
STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway. Sci Signal (2012) 3.59
Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity (2012) 3.49
Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science (2013) 3.10
The innate immune DNA sensor cGAS produces a noncanonical cyclic dinucleotide that activates human STING. Cell Rep (2013) 3.08
Immune sensing of DNA. Immunity (2013) 2.96
Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling. Cell (2013) 2.90
STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity (2014) 2.86
IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV. Science (2013) 2.68
STING manifests self DNA-dependent inflammatory disease. Proc Natl Acad Sci U S A (2012) 2.59
Structures of the HIN domain:DNA complexes reveal ligand binding and activation mechanisms of the AIM2 inflammasome and IFI16 receptor. Immunity (2012) 2.58
Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease. Hum Mol Genet (2010) 2.51
Structural mechanism of cytosolic DNA sensing by cGAS. Nature (2013) 2.50
Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination. Nat Rev Immunol (2012) 2.48
Structural analysis of the STING adaptor protein reveals a hydrophobic dimer interface and mode of cyclic di-GMP binding. Immunity (2012) 2.47
Mycobacterium tuberculosis activates the DNA-dependent cytosolic surveillance pathway within macrophages. Cell Host Microbe (2012) 2.39
Cyclic di-GMP sensing via the innate immune signaling protein STING. Mol Cell (2012) 2.38
RalB and the exocyst mediate the cellular starvation response by direct activation of autophagosome assembly. Cell (2011) 2.34
MPYS is required for IFN response factor 3 activation and type I IFN production in the response of cultured phagocytes to bacterial second messengers cyclic-di-AMP and cyclic-di-GMP. J Immunol (2011) 2.31
Mitochondria: master regulators of danger signalling. Nat Rev Mol Cell Biol (2012) 2.28
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors. Immunity (2014) 2.28
STING and the innate immune response to nucleic acids in the cytosol. Nat Immunol (2013) 2.23
Innate immune DNA sensing pathways: STING, AIMII and the regulation of interferon production and inflammatory responses. Curr Opin Immunol (2011) 2.19
Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus. Proc Natl Acad Sci U S A (2011) 2.18
STING recognition of cytoplasmic DNA instigates cellular defense. Mol Cell (2013) 2.18
Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP. Nature (2013) 2.16
Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein. Proc Natl Acad Sci U S A (2012) 2.14
TBK1 directly engages Akt/PKB survival signaling to support oncogenic transformation. Mol Cell (2011) 2.13
Molecular mechanisms of inflammasome activation during microbial infections. Immunol Rev (2011) 2.11
The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response. Nat Immunol (2012) 2.11
An innate antiviral pathway acting before interferons at epithelial surfaces. Nat Immunol (2015) 2.09
HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature (2013) 2.06
The structural basis for the sensing and binding of cyclic di-GMP by STING. Nat Struct Mol Biol (2012) 2.04
CD47 blockade triggers T cell-mediated destruction of immunogenic tumors. Nat Med (2015) 1.98
Cyclic GMP-AMP synthase is activated by double-stranded DNA-induced oligomerization. Immunity (2013) 1.98
Recognition of herpesviruses by the innate immune system. Nat Rev Immunol (2011) 1.96
Regulation of innate immune responses by autophagy-related proteins. J Cell Biol (2010) 1.94
Exorcising the exocyst complex. Traffic (2012) 1.88
Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid. J Immunol (2013) 1.85
Crystal structures of STING protein reveal basis for recognition of cyclic di-GMP. Nat Struct Mol Biol (2012) 1.82
DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog (2012) 1.80
Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA. Cell (2014) 1.70
Cyclic di-AMP: another second messenger enters the fray. Nat Rev Microbiol (2013) 1.69
IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication. Proc Natl Acad Sci U S A (2013) 1.69
Newly described pattern recognition receptors team up against intracellular pathogens. Nat Rev Immunol (2013) 1.69
Sequence-specific activation of the DNA sensor cGAS by Y-form DNA structures as found in primary HIV-1 cDNA. Nat Immunol (2015) 1.68
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity. Cell Rep (2015) 1.67
New developments in the induction and antiviral effectors of type I interferon. Curr Opin Immunol (2010) 1.67
Rad50-CARD9 interactions link cytosolic DNA sensing to IL-1β production. Nat Immunol (2014) 1.67
Innate immune pattern recognition: a cell biological perspective. Annu Rev Immunol (2015) 1.66
Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING. Nat Immunol (2012) 1.65
STING Activation by Translocation from the ER Is Associated with Infection and Autoinflammatory Disease. Cell Host Microbe (2015) 1.62
Induction and function of type I and III interferon in response to viral infection. Curr Opin Virol (2011) 1.61
Identification and characterization of a loss-of-function human MPYS variant. Genes Immun (2011) 1.60
DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. Elife (2012) 1.53
STING-dependent recognition of cyclic di-AMP mediates type I interferon responses during Chlamydia trachomatis infection. MBio (2013) 1.50
Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations. J Clin Invest (2014) 1.50
Autophagy and innate immunity: triggering, targeting and tuning. Semin Cell Dev Biol (2010) 1.49
Extensive evolutionary and functional diversity among mammalian AIM2-like receptors. J Exp Med (2012) 1.48
The E3 ubiquitin ligase TRIM21 negatively regulates the innate immune response to intracellular double-stranded DNA. Nat Immunol (2012) 1.45
Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat Med (2016) 1.45
Technologies for enhanced efficacy of DNA vaccines. Expert Rev Vaccines (2012) 1.44
Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine. Oncotarget (2013) 1.44
The mitochondrial proteins NLRX1 and TUFM form a complex that regulates type I interferon and autophagy. Immunity (2012) 1.44
Dengue virus targets the adaptor protein MITA to subvert host innate immunity. PLoS Pathog (2012) 1.44
DNA damage sensor MRE11 recognizes cytosolic double-stranded DNA and induces type I interferon by regulating STING trafficking. Proc Natl Acad Sci U S A (2013) 1.41
Species-specific detection of the antiviral small-molecule compound CMA by STING. EMBO J (2013) 1.41
Subversion of host recognition and defense systems by Francisella spp. Microbiol Mol Biol Rev (2012) 1.40
The Chlamydia trachomatis Inclusion Membrane Protein CpoS Counteracts STING-Mediated Cellular Surveillance and Suicide Programs. Cell Host Microbe (2016) 1.39
Proteasomal degradation of herpes simplex virus capsids in macrophages releases DNA to the cytosol for recognition by DNA sensors. J Immunol (2013) 1.38
NLRC3, a member of the NLR family of proteins, is a negative regulator of innate immune signaling induced by the DNA sensor STING. Immunity (2014) 1.38
The STING pathway and regulation of innate immune signaling in response to DNA pathogens. Cell Mol Life Sci (2010) 1.38
Resistance to HSV-1 infection in the epithelium resides with the novel innate sensor, IFI-16. Mucosal Immunol (2012) 1.36
Type I interferon production induced by Streptococcus pyogenes-derived nucleic acids is required for host protection. PLoS Pathog (2011) 1.36
Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood. J Exp Med (2012) 1.35
Streptococcus pneumoniae DNA initiates type I interferon signaling in the respiratory tract. MBio (2011) 1.34
TRIM32 protein modulates type I interferon induction and cellular antiviral response by targeting MITA/STING protein for K63-linked ubiquitination. J Biol Chem (2012) 1.33
5,6-Dimethylxanthenone-4-acetic acid (DMXAA) activates stimulator of interferon gene (STING)-dependent innate immune pathways and is regulated by mitochondrial membrane potential. J Biol Chem (2012) 1.33
Nuclear interferon-inducible protein 16 promotes silencing of herpesviral and transfected DNA. Proc Natl Acad Sci U S A (2013) 1.31
Innate immune sensing of DNA viruses. Virology (2011) 1.30
HSV-2: in pursuit of a vaccine. J Clin Invest (2011) 1.29
Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling. PLoS One (2012) 1.28
Activation of autophagy by α-herpesviruses in myeloid cells is mediated by cytoplasmic viral DNA through a mechanism dependent on stimulator of IFN genes. J Immunol (2011) 1.26
Intracellular pathogen detection by RIG-I-like receptors. Adv Immunol (2013) 1.25
Guanylate-binding proteins promote activation of the AIM2 inflammasome during infection with Francisella novicida. Nat Immunol (2015) 1.23
The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol (2004) 26.12
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature (2006) 22.65
Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell (2005) 20.30
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol (2005) 18.32
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature (2005) 17.47
VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell (2005) 14.20
DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature (2007) 13.56
AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature (2009) 13.23
AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature (2009) 10.83
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature (2008) 10.73
RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell (2009) 10.11
The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature (2008) 9.01
An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol (2009) 7.93
The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity (2008) 7.60
Innate immunity to virus infection. Immunol Rev (2009) 7.04
RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol (2009) 6.97
HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science (2009) 6.59
TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature (2008) 6.40
Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature (2008) 6.25
RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival. Cell (2006) 5.08
Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol (2005) 4.31
MAM: more than just a housekeeper. Trends Cell Biol (2009) 4.27
TLRs and innate immunity. Blood (2008) 3.96
Pattern recognition receptors and control of adaptive immunity. Immunol Rev (2009) 3.91
MPYS, a novel membrane tetraspanner, is associated with major histocompatibility complex class II and mediates transduction of apoptotic signals. Mol Cell Biol (2008) 3.65
Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice. J Immunol (2003) 1.81
Ral-regulated interaction between Sec5 and paxillin targets Exocyst to focal complexes during cell migration. J Cell Sci (2008) 1.68
Single copies of Sec61 and TRAP associate with a nontranslating mammalian ribosome. Structure (2008) 1.68
Processing of human cytomegalovirus UL37 mutant glycoproteins in the endoplasmic reticulum lumen prior to mitochondrial importation. J Virol (2006) 1.58
Recognition of nucleic acid and nucleic acid analogs by Toll-like receptors 7, 8 and 9. Immunobiology (2007) 1.19
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature (2008) 10.73
Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J Virol (2002) 4.31
Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome. Immunity (2011) 3.74
Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity (2012) 3.49
The dsRNA binding protein family: critical roles, diverse cellular functions. FASEB J (2003) 3.09
Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling. Cell (2013) 2.90
Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. J Immunol (2007) 2.78
STING manifests self DNA-dependent inflammatory disease. Proc Natl Acad Sci U S A (2012) 2.59
VSV disrupts the Rae1/mrnp41 mRNA nuclear export pathway. Mol Cell (2005) 2.55
Direct priming of antiviral CD8+ T cells in the peripheral interfollicular region of lymph nodes. Nat Immunol (2008) 2.52
A FADD-dependent innate immune mechanism in mammalian cells. Nature (2004) 2.50
Genetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease. J Virol (2002) 2.44
STING recognition of cytoplasmic DNA instigates cellular defense. Mol Cell (2013) 2.18
Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity. J Virol (2003) 2.10
Defective translational control facilitates vesicular stomatitis virus oncolysis. Cancer Cell (2004) 1.93
DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog (2012) 1.80
Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy. Nat Med (2007) 1.74
Fas-associated death domain-containing protein-mediated antiviral innate immune signaling involves the regulation of Irf7. J Immunol (2007) 1.62
Attenuation of vesicular stomatitis virus encephalitis through microRNA targeting. J Virol (2009) 1.46
TBK1 protects vacuolar integrity during intracellular bacterial infection. PLoS Pathog (2007) 1.43
DNA damage sensor MRE11 recognizes cytosolic double-stranded DNA and induces type I interferon by regulating STING trafficking. Proc Natl Acad Sci U S A (2013) 1.41
The STING pathway and regulation of innate immune signaling in response to DNA pathogens. Cell Mol Life Sci (2010) 1.38
Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: key regulators of innate immunity. Pharmacol Ther (2009) 1.37
TAX1BP1 and A20 inhibit antiviral signaling by targeting TBK1-IKKi kinases. J Biol Chem (2010) 1.29
The cellular protein P58IPK regulates influenza virus mRNA translation and replication through a PKR-mediated mechanism. J Virol (2006) 1.28
Adenoviral transfer of the melanoma differentiation-associated gene 7 (mda7) induces apoptosis of lung cancer cells via up-regulation of the double-stranded RNA-dependent protein kinase (PKR). Cancer Res (2002) 1.26
Melanoma differentiation-associated gene-7 protein physically associates with the double-stranded RNA-activated protein kinase PKR. Mol Ther (2005) 1.23
Safety studies on intrahepatic or intratumoral injection of oncolytic vesicular stomatitis virus expressing interferon-beta in rodents and nonhuman primates. Hum Gene Ther (2010) 1.18
Cytosolic-DNA-mediated, STING-dependent proinflammatory gene induction necessitates canonical NF-κB activation through TBK1. J Virol (2014) 1.16
Use of biological therapy to enhance both virotherapy and adoptive T-cell therapy for cancer. Mol Ther (2008) 1.16
PKR in innate immunity, cancer, and viral oncolysis. Methods Mol Biol (2007) 1.15
Interference of CD40L-mediated tumor immunotherapy by oncolytic vesicular stomatitis virus. Hum Gene Ther (2010) 1.15
Azidothymidine inhibits NF-kappaB and induces Epstein-Barr virus gene expression in Burkitt lymphoma. Blood (2005) 1.14
NFAR-1 and -2 modulate translation and are required for efficient host defense. Proc Natl Acad Sci U S A (2008) 1.14
Evaluation of an attenuated vesicular stomatitis virus vector expressing interferon-beta for use in malignant pleural mesothelioma: heterogeneity in interferon responsiveness defines potential efficacy. Hum Gene Ther (2010) 1.14
Cutting edge: DNA sensing via the STING adaptor in myeloid dendritic cells induces potent tolerogenic responses. J Immunol (2013) 1.13
STING-dependent signaling. Nat Immunol (2011) 1.08
The oncolytic effect of recombinant vesicular stomatitis virus is enhanced by expression of the fusion cytosine deaminase/uracil phosphoribosyltransferase suicide gene. Cancer Res (2003) 1.08
Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-kappa B. Blood (2002) 1.05
Endoplasmic reticulum stress regulates the innate immunity critical transcription factor IRF3. J Immunol (2012) 1.04
Defects in translational regulation mediated by the alpha subunit of eukaryotic initiation factor 2 inhibit antiviral activity and facilitate the malignant transformation of human fibroblasts. Mol Cell Biol (2004) 1.03
Oncogenic IRFs provide a survival advantage for Epstein-Barr virus- or human T-cell leukemia virus type 1-transformed cells through induction of BIC expression. J Virol (2011) 1.00
Treg depletion-enhanced IL-2 treatment facilitates therapy of established tumors using systemically delivered oncolytic virus. Mol Ther (2008) 1.00
A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen. Arthritis Rheum (2006) 1.00
Phosphorylation of the NFAR proteins by the dsRNA-dependent protein kinase PKR constitutes a novel mechanism of translational regulation and cellular defense. Genes Dev (2010) 0.99
Evaluating replication-defective vesicular stomatitis virus as a vaccine vehicle. J Virol (2006) 0.98
Generation of hepatitis C virus-like particles by use of a recombinant vesicular stomatitis virus vector. J Virol (2002) 0.97
Retargeting vesicular stomatitis virus using measles virus envelope glycoproteins. Hum Gene Ther (2012) 0.95
The alpha subunit of eukaryotic initiation factor 2B (eIF2B) is required for eIF2-mediated translational suppression of vesicular stomatitis virus. J Virol (2011) 0.93
Vesicular stomatitis virus inhibits mitotic progression and triggers cell death. EMBO Rep (2009) 0.92
Role for the double-stranded RNA activated protein kinase PKR in E2F-1-induced apoptosis. Oncogene (2002) 0.92
The double-stranded RNA-activated protein kinase mediates radiation resistance in mouse embryo fibroblasts through nuclear factor kappaB and Akt activation. Clin Cancer Res (2007) 0.90
Early virus-associated bystander events affect the fitness of the CD8 T cell response to persistent virus infection. J Immunol (2007) 0.89
Impaired cellular responses to cytosolic DNA or infection with Listeria monocytogenes and vaccinia virus in the absence of the murine LGP2 protein. PLoS One (2011) 0.89
Molecular characterization of Streptococcus agalactiae isolated from bovine mastitis in Eastern China. PLoS One (2013) 0.88
Differential tissue targeting of autoimmunity manifestations by autoantigen-associated Y RNAs. Arthritis Rheum (2007) 0.88
Vesicular stomatitis virus expressing tumor suppressor p53 is a highly attenuated, potent oncolytic agent. J Virol (2011) 0.88
PEGylation of vesicular stomatitis virus extends virus persistence in blood circulation of passively immunized mice. J Virol (2013) 0.87
DDX24 negatively regulates cytosolic RNA-mediated innate immune signaling. PLoS Pathog (2013) 0.87
Primary epithelioid hemangioendothelioma of the bladder: case report and review of the literature. Urol Int (2014) 0.86
Intrahepatic interleukin-17+ T cells and FoxP3+ regulatory T cells cooperate to promote development and affect the prognosis of hepatocellular carcinoma. J Gastroenterol Hepatol (2014) 0.86
Histomorphometric analysis of adult articular calcified cartilage zone. J Struct Biol (2009) 0.85
Novel c-di-GMP recognition modes of the mouse innate immune adaptor protein STING. Acta Crystallogr D Biol Crystallogr (2013) 0.84
Explicit targeting of transformed cells by VSV in ovarian epithelial tumor-bearing Wv mouse models. Gynecol Oncol (2009) 0.83
Modulation of Ca²⁺ signals by epigallocatechin-3-gallate(EGCG) in cultured rat hippocampal neurons. Int J Mol Sci (2011) 0.81
Compact optical short-pass filters based on microfibers. Opt Lett (2008) 0.80
Vesiculovirus neutralization by natural IgM and complement. J Virol (2014) 0.79
Biofilm formation of Streptococcus equi ssp. zooepidemicus and comparative proteomic analysis of biofilm and planktonic cells. Curr Microbiol (2014) 0.79
Activation of double-stranded RNA dependent protein kinase, a new pathway by which human polynucleotide phosphorylase (hPNPase(old-35)) induces apoptosis. Cancer Res (2007) 0.79
Diffuse large B-cell lymphoma involving the central nervous system. Int J Surg Pathol (2010) 0.79
Potential of vesicular stomatitis virus as an oncolytic therapy for recurrent and drug-resistant ovarian cancer. Chin J Cancer (2011) 0.79
Evaluation of innate immune signaling pathways in transformed cells. Methods Mol Biol (2012) 0.78
All-trans-retinal sensitizes human RPE cells to alternative complement pathway-induced cell death. Invest Ophthalmol Vis Sci (2013) 0.78
[Typical carcinoid tumor of the larynx with inguinal lymphatic metastasis]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2013) 0.78
Contribution of fibronectin-binding protein to pathogenesis of Streptococcus equi ssp. zooepidemicus. Pathog Dis (2013) 0.77
T-cell leukemia 1 expression in nodal Epstein-Barr virus-negative diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma. Hum Pathol (2010) 0.77
Identification of genes transcribed by Streptococcus equi ssp. zooepidemicus in infected porcine lung. Microb Pathog (2013) 0.77
The identification of six novel proteins with fibronectin or collagen type I binding activity from Streptococcus suis serotype 2. J Microbiol (2014) 0.76
Identifying the phase behavior of biodegradable poly(hexamethylene succinate-co-hexamethylene adipate) copolymers with FTIR. J Phys Chem B (2009) 0.76
Pediatric lymphomas in Brazil. Clinics (Sao Paulo) (2010) 0.76
[Diagnostic value of absent ductular reaction at hepatocellular-stromal boundaries in early stage hepatocellular carcinoma]. Zhonghua Gan Zang Bing Za Zhi (2013) 0.76
Construction and immunogenicity of recombinant swinepox virus expressing capsid protein of PCV2. Vaccine (2012) 0.75
The expression of thymosin β4 in chronic hepatitis B combined nonalcoholic fatty liver disease. Medicine (Baltimore) (2016) 0.75
Identification of a novel collagen type І-binding protein from Streptococcus suis serotype 2. Vet J (2013) 0.75
[Application of single stapler combined with prolapsing technique in anterior resection of ultra-low rectal cancer]. Zhonghua Yi Xue Za Zhi (2006) 0.75
[Application of autogenous bone pate for atticus reconstruction and mastoid cavity obliteration in tympanoplasty with mastoidectomy]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2013) 0.75
Single-nanowire surface plasmon gratings. Nanotechnology (2012) 0.75
Modeling endface output patterns of optical micro/nanofibers. Opt Express (2008) 0.75
Self-regulation in flow-induced structure formation of polypropylene. Macromol Rapid Commun (2014) 0.75
Enhanced healing of rat calvarial critical size defect with selenium-doped lamellar biocomposites. Biol Trace Elem Res (2013) 0.75
Plasmonic resonance of whispering gallery modes in an Au cylinder. Opt Express (2011) 0.75
Photonic generation of ultrawideband signals based on a gain-switched semiconductor laser with optical feedback. Appl Opt (2013) 0.75
Diode-pumped efficient slab laser with two Nd:YLF crystals and second-harmonic generation by slab LBO. Opt Lett (2007) 0.75
Corrigendum: Construction and immunogenicity of a recombinant swinepox virus expressing a multi-epitope peptide for porcine reproductive and respiratory syndrome virus. Sci Rep (2017) 0.75
[A case report of primary malignant melanoma of the liver diagnosed by percutaneous liver biopsy]. Zhonghua Gan Zang Bing Za Zhi (2013) 0.75
Diode-end-pumped double Nd:YLF slab laser with high energy, short pulse width, and diffraction-limited quality. Opt Lett (2008) 0.75